This study compared the sociodemographic and cardiovascular correlates of oral contraceptive users and nonusers between 1981 and 1993. We also sought to determine changes in the prevalence of oral contraceptive use among older premenopausal women. Using data from six biennial cross-sectional household surveys in a population-based sample of two New England communities, 5239 women between ages 18 and 45 years were identified. Women using oral contraceptives were 5 years younger and better educated than nonusers, and users more frequently reported a per capita income above the median for the survey population than nonusers. Users were more likely to report smoking and have a lower body mass index than nonusers. Little use of oral contraceptives was detected among women ages 40-45 years despite changes in FDA recommendations about their use and increasing evidence of their noncontraceptive benefits in healthy older nonsmoking women.

HomeCirculationVol. 93, No. 9Report of the Expert Panel on Awareness and Behavior Change to the Board of Directors, American Heart Association Free AccessResearch ArticleDownload EPUBAboutView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessResearch ArticleDownload EPUBReport of the Expert Panel on Awareness and Behavior Change to the Board of Directors, American Heart Association Richard A. Carleton, Terry Bazzarre, John Drake, Andrea Dunn, Edwin B. FisherJr, Scott M. Grundy, Laura Hayman, Martha N. Hill, Edward W. Maibach, James Prochaska, Tom Schmid, Sidney C. SmithJr, Mervyn W. Susser and John W. Worden Richard A. CarletonRichard A. Carleton , Terry BazzarreTerry Bazzarre , John DrakeJohn Drake , Andrea DunnAndrea Dunn , Edwin B. FisherJrEdwin B. FisherJr , Scott M. GrundyScott M. Grundy , Laura HaymanLaura Hayman , Martha N. HillMartha N. Hill , Edward W. MaibachEdward W. Maibach , James ProchaskaJames Prochaska , Tom SchmidTom Schmid , Sidney C. SmithJrSidney C. SmithJr , Mervyn W. SusserMervyn W. Susser and John W. WordenJohn W. Worden Originally published1 May 1996https://doi.org/10.1161/01.CIR.93.9.1768Circulation. 1996;93:1768–1772The Board of Directors of the American Heart Association charged the Expert Panel on Awareness and Behavior Change to:Evaluate the available data on the strengths and limitations of health education strategies targeted at increasing awareness of the benefits of cardiovascular risk factor management compared with strategies that specifically promote behavioral change.Consider the relative role of alternative strategies such as policy making and media campaigns in achieving the AHA's educational mission. The panel was asked to evaluate the AHA Strategic Plans for Consumer Nutrition Education and Promoting Physical Activity.Address the following questions: How can the AHA best invest its finite resources? Should the AHA's educational goals focus on and measure success through public knowledge and awareness of cardiovascular risk factors or behavioral change related to specific risk factors?Develop recommendations on how the AHA can best allocate its limited resources for health education and identify appropriate new methods of evaluating the effectiveness of its programs.Panel members reviewed background material on the structure and function of the AHA, then met in Dallas on October 17, 1995. Extensive discussions and the subsequent deliberations clarified the purpose of the decisions to be made by the Board of Directors. The panel spent a substantial amount of time and effort evaluating alternatives and assessing the strengths and risks or limitations of each. These alternatives are presented in Tables 1 through 5. This report presents the recommendations of the Expert Panel to the Board of Directors.Throughout these discussions the American Heart Association mission, "To reduce disability and death from cardiovascular diseases and stroke," was kept in mind. Consideration of the mission and the charge to the panel led to discussion of influences and steps toward fulfillment of this mission by the American public. This process is depicted in the Figure as an arrow.The central core of the arrow illustrates a sequence of change by individuals, groups of individuals, segments of the population, or the entire population. The arrow depicts a sequence from awareness (Table 1) of a modifiable health-related problem, through acquisition of skills to change behaviors that influence health, to actual altered behaviors (Table 2) that lead to a modification of risk factors, and finally to a decrease in disability and death from cardiovascular disease. The Figure also recognizes several powerful influences on risk (Table 3) and, ultimately, on disease: the physical environment in which we live; the social environment that influences our actions and behaviors; national and local policies that impact behaviors; and the role of the healthcare system itself in the entire sequence.The AHA's programs and messages (Table 4) are designed to fulfill its mission by reaching and favorably influencing the awareness, knowledge, behavior, risk, and health of all Americans. The panel has reviewed many of the principles of reaching large audiences. Programs can be targeted at individual, group, organization, community, or population-wide levels. The data clearly indicate that it is easier to arouse awareness than to change behavior. Yet behavioral change is a major step in fulfillment of the AHA mission. The panel recognizes the efficacy of programs targeting individuals and small groups. The panel also reviewed the evidence that suggests that community-based programs have achieved modest results, at best. The panel analyzed the evidence of the remarkable success of the AHA and its allied agencies, both governmental and nongovernmental, in producing favorable trends in most behaviors, cardiovascular risk factors, and age-adjusted death and disability rates. Many of these changes reflect programs, policies, and practices implemented at the national level through coalition building and advocacy.Accordingly, the panel does not recommend that the AHA seek an "either/or" decision concerning emphasis on awareness or behavioral change. Similarly, the AHA should not focus exclusively on either small-group programs or state- or national-level advocacy efforts. Instead, the panel recommends that many strategies and tactics have a place in moving the population toward achievement of the AHA mission (Table 5).Careful consideration of these factors has led the panel to present the following recommendations to the AHA Board of Directors for approval. These recommendations involve the program, evaluation, and structure of the AHA.Program1. Programs, messages, and educational strategies should be designed and implemented with the expectation that they are likely to move the population toward fulfillment of the AHA mission. There is no need to focus on any one element to the exclusion of others.2. The AHA should continue to use social marketing principles to identify the element to be influenced, specific target audiences, optimal educational strategies, and the most effective means of meeting the specific needs of the target audience.3. Programs should be based on tested theory whenever possible but can and should vary in expected outcome. Efforts to seek behavioral and risk factor change in population groups at higher risk of disability and death from cardiovascular disease is not only important but cost-effective. Those in the early stages of behavioral change may be moved by awareness and increased knowledge toward adopting more healthy behaviors.4. Programs to enhance the visibility of the AHA and generate resources are in keeping with efforts to move the population toward fulfillment of the AHA mission. Such messages, when combined with actual behavioral change, enhance a social environment that promotes good health.5. Program messages that are based on sound scientific evidence and consensus within the AHA must also be understood by the public. Nutritional information deemed appropriate by the AHA's science component may not be communicated at the level of comprehension required by the AHA's program component. For example, a catchy, yet scientifically sound message such as "5-a-day" may be a better program message than "Eat five servings of fruits and vegetables daily." Similarly, use of the terms "skim" or "1%" to describe low-fat or low–saturated fat dairy products may be more comprehensible to certain population segments. Describing a 3-ounce portion of meat as being the size of a deck of cards may be helpful to others.6. To optimize the use of its resources in fulfillment of its mission, effective AHA programs and messages (as judged through internal or external evaluation) delivered through the appropriate channels to responsive audiences are needed. Similarly, ineffective or unproved programs of limited reach (inappropriate or unresponsive audiences) should be discontinued.7. When feasible, coalitions with other organizations that share the AHA's goals in programming, visibility, and fund-raising should be formed and nurtured to present concerted rather than discordant or confusing messages to the public. An excellent example is the Coalition on Smoking OR Health. Previous efforts to develop a sustained multiagency coalition effort promoting an all-American diet should be resumed, even if the messages used originate from other agencies. Messages about nutrition and other behavioral changes should be communicated by several agencies in the same terms to avoid confusing the public.Evaluation1. Precise evaluation is costly. Given its limited resources, it is appropriate for the AHA to use a variety of methods to evaluate its programs and messages. Programs clearly indicated by previous data as successful in generating awareness, changing knowledge, or changing behavior (or even image enhancement and fund-raising) do not require additional evaluation. Program evaluation should be used to the extent required to show that products are effective and that they reach targeted individuals. Product designs based on previously tested principles may require only limited formative pretests with targeted individuals, coupled with process tracking to ensure delivery. When evaluation data are limited, pilot testing is necessary. Formative evaluation is particularly important for new approaches, such as interactive computer programs. Subsequent versions of the same approach do not require outcome assessment (eg, awareness or behavior).2. It is recommended that the AHA not use its resources to conduct long-term follow-up of behavioral change by all program participants. Extrapolation from pilot data or data obtained from other sources is a practical measure of the effectiveness of such efforts.3. It is recommended that the AHA not expect to be able to conclusively attribute long-term risk factor or cardiovascular disease disability or death trends to a single program or even its own global efforts. To be part of a movement toward fulfillment of the AHA mission is sufficient.4. Proper topics for AHA research support, in addition to basic molecular and clinical science, include public health disciplines such as health communications, health marketing, health services, behavioral medicine, program evaluation, and evaluation of individual and collective behavior. Research in these disciplines will enhance understanding of formulation, delivery, and evaluation of effective programs and messages within the AHA and elsewhere.5. Collaborative efforts in evaluation, as in program delivery, are worthy of consideration. Industry partners (eg, members of the Pharmaceutical Roundtable or other pharmaceutical/medical equipment manufacturers) may want to support program evaluation. A partnership with the Centers for Disease Control and Prevention (CDC) may provide opportunities to use or even add questions to the Behavioral Risk Factor Surveillance System on a national, regional, or state basis. In turn, pilot tests of programs or messages on a state or regional basis may facilitate evaluation through such a partnership. The National Center for Health Statistics National Health and Nutrition Examination Survey (NHANES) may also provide low-cost evaluative resources.6. Consider creation of a mechanism to set aside a portion of AHA research funds to support rigorous program evaluation as needed through a Request for Proposals, developed cooperatively by the science and program components of the AHA.Structure1. Continued use of market teams to reach specific target audiences and the flexibility to create new teams or modify existing teams is recommended.2. Program and channel prioritization processes should continue to include analyses of population segments, their risk level, ease and cost of access, cost-effectiveness, and likelihood of useful outcomes based on stage of change. This prioritization matrix should be reevaluated at least biennially.3. It is important that AHA staff and volunteers in the areas of science, program, and communications have effective ongoing communication, common goals, and common messages. Accordingly, the Science Advisory and Coordinating Committee should include as regular members persons with expertise in community program design and delivery as well as persons with a public health communications background.4. The Board of Directors must ensure better communication among these groups so that credible and comprehensible awareness and behavioral change programs and messages are delivered to and received by the public. In the event of disagreement, the Board should decide how scientifically credible programs and messages are best delivered.BibliographyCommentary/PerspectivesFisher EB Jr. The results of the COMMIT trial: Community Intervention Trial for Smoking Cessation. Am J Public Health. 1995;85:159-160.Fortmann SP, Flora JA, Winkleby MA, Schooler C, Taylor CB, Farquhar JW. Community intervention trials: reflections on the Stanford Five-City Project Experience. Am J Epidemiol. 1995;142:576-586.Green SB, Corle DK, Gail MH, Mark SD, Pee D, Freedman LS, Graubard BI, Lynn WR. Interplay between design and analysis for behavioral intervention trials with community as the unit of randomization. Am J Epidemiol. 1995;142:587-593.Koepsell TD, Diehr PH, Cheadle A, Kristal A. Invited commentary: symposium on community intervention trials. Am J Epidemiol. 1995;142:594-599.Lefebvre RC, Lurie D, Goodman LS, Weinberg L, Loughrey K. Social marketing and nutrition education: inappropriate or misunderstood? J Nutrition Ed. 1995;27:146-150.McAlister A. Behavioral journalism: beyond the marketing model for health communication. Am J Health Promotion. 1995;9:417-420.Mittelmark MB, Hunt MK, Heath GW, Schmid TL. Realistic outcomes: lessons from community-based research and demonstration programs for the prevention of cardiovascular diseases. J Public Health Policy. 1993;14:437-462.Murray DM. Design and analysis of community trials: lessons from the Minnesota Heart Health Program. Am J Epidemiol. 1995;142:569-575.Susser M. The tribulations of trials: intervention in communities. Am J Public Health. 1995;85:156-158.Vanden Heede FA, Pelican S. Reflections on marketing as an inappropriate model for nutrition education. J Nutrition Ed. 1995;27:141-145.Research ReportsAirhihenbuwa CO, Kumanyika S, Agurs TD, Lowe A. Perceptions and beliefs about exercise, rest, and health among African-Americans. Am J Health Promotion. 1995;9:426-429.Blum A. Paid counter-advertising: proven strategy to combat tobacco use and promotion. Am J Prev Med. 1994;10(suppl 3):8-10.Campbell MK, DeVellis BM, Strecher VJ, Ammerman AS, DeVellis RF, Sandler RS. Improving dietary behavior: the effectiveness of tailored messages in primary care settings. Am J Public Health. 1994;84:783-787.Cardinal BJ, Sachs ML. Prospective analysis of stage-of-exercise movement following mail-delivered, self-instructional exercise packets. Am J Health Promotion. 1995;9:430-432.Carleton RA, Lasater TM, Assaf AR, Feldman HA, McKinlay S. The Pawtucket Heart Health Program: community changes in cardiovascular risk factors and projected disease risk. Am J Public Health. 1995;85:777-785.Community Intervention Trial for Smoking Cessation (COMMIT), I: cohort results from a four-year community intervention. Am J Public Health. 1995;85:183-192.Community Intervention Trial for Smoking Cessation (COMMIT), II: changes in adult cigarette smoking prevalence. Am J Public Health. 1995;85:193-200.Davis DA, Thomson MA, Oxman AD, Haynes RB. Changing physician performance: a systematic review of the effect of continuing medical education strategies. JAMA. 1995;274:700-705.Emont SL, Zahniser SC, Marcus SE, Trontell AE, Mills S, Frazier EL, Waller MN, Giovino GA. Evaluation of the 1990 Centers for Disease Control and Prevention smoke-free policy. Am J Health Promotion. 1995;9:456-461.Farquhar JW, Fortmann SP, Flora JA, Taylor CB, Haskell WL, Williams PT, Maccoby N, Wood PD. Effects of communitywide education on cardiovascular disease risk factors: the Stanford Five-City Project. JAMA. 1990;264:359-365.Gemson DH, Sloan RP. Efficacy of computerized health risk appraisal as part of a periodic health examination at the worksite. Am J Health Promotion. 1995;9:462-466.Goodman RM, Wheeler FC, Lee PR. Evaluation of the Heart To Heart Project: lessons from a community-based chronic disease prevention project. Am J Health Promotion. 1995;9:443-455.Holt MC, McCauley M, Paul D. Health impacts of AT&T's Total Life Concept (TLC) Program after five years. Am J Health Promotion. 1995;9:421-425.Luepker RV, Murray DM, Jacobs DR Jr, Mittelmark MB, Bracht N, Carlaw R, Crow R, Elmer P, Finnegan J, Folsom AR, et al. Community education for cardiovascular disease prevention: risk factor changes in the Minnesota Heart Health Program. Am J Public Health. 1994;84:1383-1393.Requests for reprints should be sent to the Office of Scientific Affairs, American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231-4596.Download figureDownload PowerPoint Figure 1. Influences and steps toward fulfillment of the American Heart Association mission. CVD indicates cardiovascular disease. Table 1. Awareness and Knowledge as Elements of Heart-Health PromotionStrengthsLimitations• Programs or messages that increase awareness and knowledge may be all that some segments of the target population are ready to attend or receive.• Studies and surveys suggest that many respondents already have a high level of awareness and knowledge but lack the skills for or need additional information on how to make behavioral changes.• Increased awareness and knowledge is often a necessary first step before behavioral change.• Awareness and knowledge are universally perceived as insufficient for promotion and maintenance of long-term behavioral change.• People are motivated and helped to change their behaviors.• Lack of impact on many population segments limits benefit.• Changes in awareness and knowledge can be relatively easy to measure.• Documented changes in awareness and knowledge do not ensure that risk factors or disease rates will change.• It is relatively easy to reach large numbers of people.• "Dose" is usually low.• Readiness to learn can change over time and vary across situations and behaviors.• The benefits of awareness and knowledge programs are dependent on the readiness of the audience to learn and individual learning styles. Acceptance of programs is also influenced by cultural norms.• Information can be presented in stepped levels of complexity and adapted to specific audiences.• If too complex, some programs or messages can be ineffective.• Use of information is influenced by the credibility of the source. The AHA is viewed as a very credible source. This view can be enhanced through better communication between the AHA's science and program components.• In the interest of maintaining its credibility, the AHA may be slow to respond to or be associated with issues without 100% consensus. Such a consensus can be difficult to achieve when bridging the science and program components of the AHA.• The effectiveness of a program or message is often proportional to the strength of the science on which it is based.• A weak, incomplete, or inconsistent science base limits choices of program topics and program effectiveness (eg, trans fatty acids, antioxidants).• The visibility of programs for change in awareness and knowledge enhance public perception of the AHA and facilitate fund-raising.• Too great a focus on fund-raising may dilute the message of change. Table 2. Cardiovascular Disease Risk Factor–Related Behavioral Change as an Element of Heart-Health PromotionStrengthsLimitations• Behavioral change is a necessary and often sufficient step toward changing risk and reducing disease and thus is near the "bottom line."• Behavioral change is more complex and usually requires awareness, knowledge, and skill.• Behavioral change may be the only appropriate outcome for certain programs or approaches.• The intensity and cost of successful behavioral change programs is relatively high.• Programs can be targeted to a segment of the audience: for example, "overexposed," ready-to-change population segments can create a social environment of "exemplars" who influence later "adopters."• Behavioral change may miss population segments that are less ready to change but at greater risk.• Behavioral change can be targeted differently to reach those for whom behavioral change is cost-effective.• It is impractical to aim programs and messages at those who will not or who do not need to change or for whom behavioral change will not alter disability or disease outcomes.• Strong messages from multiple agencies and sources, with similar phrasing and imagery are likely to influence the social-informational environment and foster greater change (eg, the "5-a-day" message from the USDA, the AHA, the National Institutes of Health, the American Cancer Society, and industry).• Coalitions require effort and resources to build. Table 3. Influencing the Physical and Social Environments and the Healthcare System Through Advocacy and Policy Changes as Elements of Heart-Health PromotionStrengthsLimitations• Policy changes through effective advocacy can be a powerful force for change in social environment.• It is difficult to conduct focal evaluation permitting causal attribution.• Policy changes are effective for changing physical and social environment and powerfully influencing behavior (eg, smoking disincentives by policy, regulation, law, or economic means).• Some initiatives create antagonism in some segments of society (eg, users of tobacco products).• Policy changes are effective on the societal and environmental levels.• Limited knowledge, especially of second- or third-level effects of policy or legal changes, limits ability to gauge effectiveness (eg, does the dairy subsidy now enhance lower or higher milk-fat consumption?).• Policy changes are applicable at multiple levels of society and organizations such as worksites or clubs and community, state, and national programs. They are available at the national, affiliate, and divisional levels and through multiple channels: legislative, regulatory, marketing, lobbying, and proclamations.• Policy changes are especially controversial in a political environment favoring fewer governmental directives or regulations. Effectiveness is influenced by soundness of the science; social, political, and financial costs; and advocacy skills.• Implementation at multiple levels or in stages is possible:−Restricted or facilitated production−Restricted or facilitated sale of products−Raised or lowered taxes on products• The best effect, often requiring multiple levels simultaneously, can be difficult to achieve.• Specific locations (restaurants, airlines), regions (eg, the Northeast, the Southwest), and population segments (eg, young black men, older white women) can be targeted.• Creation of a class of "pariahs" is possible, causing isolation, lowered self-esteem, and possible antagonism toward certain population segments (eg, smokers).• All elements or organizations can be influenced from management down or across disciplines, and multiple organizations or multisite organizations can be linked to a common goal.• Coordination of AHA resources at all levels under the direction of the Board of Directors is required.• Simple messages can be used to create action orientation. A gradual or staged approach can be used to foster evolution rather than revolution.• Clear policy development, ability to focus on simple messages, and endorsement by the Board of Directors are needed. Table 4. Media, Other Information Paths, and Social Marketing as a Means of Influencing Heart-Health PromotionStrengthsLimitations• Population analyses can identify special audiences by characteristics such as age, demographic features, literacy, etc.• Analyses to identify narrow audience segments can be costly.• Information, programs, and products can be developed, tested, and delivered to meet the needs and interests of specific target audiences.• Product targeting requires special expertise and resources.• The media represents only a single important channel for social marketing.• Reception varies by the medium used; selecting the best media channels for each targeted population segment is difficult.• Simple messages implemented with multiple exposures and follow-up activities are often the most effective and powerful.• Simple messages may not convey the entire scientific base or complete accuracy, posing concern for some segments of the AHA. Ongoing investment for repetition is required.• Frequency and reach can be measured.• Accuracy of inferences about impact may be suspect but improved if accepted marketing methods are used.• Impact of information transmitted can be estimated.• Accurate measurement of impact is more costly.• Adaptation for delivery through the information superhighway is possible.• Reach and impact are more difficult to assess. Assessment is limited to certain audience segments at present.• Large numbers of people can be reached, and the program can be designed to reach the "hard to reach."• Audience research and multiple special programs or messages can be costly.• Some options, such as public service time, may be free or low cost.• Purchased space or time can be costly, but equivalent public service time is often available.• There is potential for sponsorships and partnerships with industry, governmental agencies, and other voluntary health agencies.• Ensuring that messages and programs are acceptable to all partners may involve compromising the accuracy or completeness of the message.• It is possible to develop powerful and memorable visual or audible images.• Simple concepts may require careful design and testing to avoid compromising the integrity of the science base.• Modeling of behaviors can be displayed or described to narrowly defined audiences.• Use of audience-specific models may limit reach or impact on targeted subpopulations.• Some channels (eg, interactive computer programs) are compatible with the learning styles of a relatively small segment of the total population.• Some distribution channels are not effective or are unavailable for many others.• Many channels (eg, infomercials, public service announcements, paid advertising, entertainment programs and documentaries, and on-line chat rooms) are available.• Effective use of each distribution channel requires development, implementation, and evaluation by staff with relevant experience. Table 5. Evaluation as a Means of Measuring Progress in Heart-Health PromotionStrengthsLimitations• Measurement of risk factors provides accuracy and assurance and is directly relevant to the AHA's mission. Self-reported data are also useful.• Cost for actual risk factor measurement is highest. Cost for self-reported behaviors is lower.• Adding on or adapting ongoing AHA Random Digit Dialing surveys is a cost-effective approach.• Add-ons may infringe on the purpose of the survey.• Adding on to surveys by potential partners (eg, the CDC's Behavioral Risk Factor Surveillance System) by region, state, or nation, or adopting or adding queries to other data sources such as NHANES are other possibilities.• Cooperative efforts with other agencies, such as the American Cancer Society, the American Lung Association, and the American Diabetes Association, may be required.• Some programs can be formatively evaluated only and results, if obtained in pilot testing, generalized to subsequent versions of the program.• Generalization of results will be limited if new groups of participants differ demographically.• Measuring distribution of materials or messages can be an inexpensive alternative for measuring change in awareness or knowledge.• Low cost is paralled by low precision in estimating impact. Distribution may not be an adequate alternative, especially among population segments with low education or receptivity.• Trends in risk factors and disease provide a measure of efficacy.• The ability to discern the specific impact of AHA efforts from those of other agencies is limited.• A registry of program participants permits audience characterization and follow-up.• Registries can be costly in terms of staff time and participant burden.• Evaluation is critical to learn what works and to avoid wasting resources on what doesn't.• Accurate evaluation data that meet standards of validity and reliability are often expensive.• It is desirable to evaluate changes in various population subgroups.• Evaluation resources are limited and require a focus on testing audiences likely to make changes.CDC indicates Centers for Disease Control and Prevention; NHANES, National Health and Nutrition Examination Survey. Previous Back to top Next FiguresReferencesRelatedDetailsCited By Brouwer‐Goossensen D, Hertog H, Mastenbroek‐de Jong M, Gemert‐Pijnen L and Taal E (2021) Patient perspectives on health‐related behavior change after transient ischemic attack or ischemic stroke, Brain and Behavior, 10.1002/brb3.1993, 11:4, Online publication date: 1-Apr-2021. Donohoe H, Omodior O and Roe J (2018) Tick-borne disease occupational risks and behaviors of Florida Fish, Wildlife, and Parks Service employees – A health belief model perspective, Journal of Outdoor Recreation and Tourism, 10.1016/j.jort.2018.02.003, 22, (9-17), Online publication date: 1-Jun-2018. Omodior O, Luetke M and Nelson E (2018) Mosquito-borne infectious disease, risk-perceptions, and personal protective behavior among U.S. international travelers, Preventive Medicine Reports, 10.1016/j.pmedr.2018.10.018, 12, (336-342), Online publication date: 1-Dec-2018. Brown N (2015) How the American Heart Association Helped Change Women's Heart Health, Circulation: Cardiovascular Quality and Outcomes, 8:2_suppl_1, (S60-S62), Online publication date: 1-Mar-2015. Coady M, Chan C, Auer K, Farley S, Kilgore E and Kansagra S (2012) Awareness and impact of New York City's graphic point-of-sale tobacco health warning signs, Tobacco Control, 10.1136/tobaccocontrol-2011-050261, 22:e1, (e51-e56), Online publication date: 1-May-2013. Berra K (2010) Challenges of Changing Lifestyle to Reduce Risk for Cardiovascular Disease, Journal of Cardiovascular Nursing, 10.1097/JCN.0b013e3181cec7e4, 25:3, (223-227), Online publication date: 1-May-2010. Berra K, Klieman L and Hinohara A (2009) Promoting adherence to medical and lifestyle interventions for women with cardiovascular disease, Current Cardiovascular Risk Reports, 10.1007/s12170-009-0031-x, 3:3, Online publication date: 1-May-2009. Borges G, Wang P, Medina-Mora M, Lara C and Chiu W (2007) Delay of First Treatment of Mental and Substance Use Disorders in Mexico, American Journal of Public Health, 10.2105/AJPH.2006.090985, 97:9, (1638-1643), Online publication date: 1-Sep-2007. Ritter M, Brach S, Rogalewski A, Dittrich R, Dziewas R, Weltermann B, Heuschmann P and Nabavi D (2013) Discrepancy between theoretical knowledge and real action in acute stroke: self-assessment as an important predictor of time to admission, Neurological Research, 10.1179/016164107X163202, 29:5, (476-479), Online publication date: 1-Jul-2007. Schmidt N, H�wel J and Weisner B (2005) Ursachen einer verl�ngerten Pr�hospitalphase bei Stroke-Unit-PatientenCauses of a prolonged prehospital phase in patients admitted to a stroke unit, Der Nervenarzt, 10.1007/s00115-004-1785-5, 76:2, (181-185), Online publication date: 1-Feb-2005. Demirovic J (2004) Cardiopulmonary Resuscitation Programs Revisited: Results of a Community Study Among Older African Americans, The American Journal of Geriatric Cardiology, 10.1111/j.1076-7460.2004.02525.x, 13:4, (182-187), Online publication date: 1-Jul-2004. Wang P, Berglund P, Olfson M and Kessler R (2004) Delays in Initial Treatment Contact after First Onset of a Mental Disorder, Health Services Research, 10.1111/j.1475-6773.2004.00234.x, 39:2, (393-416), Online publication date: 1-Apr-2004. Wang P, Demler O and Kessler R (2002) Adequacy of Treatment for Serious Mental Illness in the United States, American Journal of Public Health, 10.2105/AJPH.92.1.92, 92:1, (92-98), Online publication date: 1-Jan-2002. Nordmann A, Heilmbauer I, Walker T, Martina B and Battegay E (2001) A case-management program of medium intensity does not improve cardiovascular risk factor control in coronary artery disease patients: the Heartcare I Trial, The American Journal of Medicine, 10.1016/S0002-9343(01)00682-9, 110:7, (543-550), Online publication date: 1-May-2001. Maisano G, Molinis G, Tuniz D and Valente M (1998) Rehabilitation and secondary prevention in patients with cardiovascular diseases, The Italian Journal of Neurological Sciences, 10.1007/BF00713887, 19:S1, (S48-S50), Online publication date: 1-Oct-1998. Lahart I, Reichl C, Metsios G, Nevill A and Carmichael A (2014) Physical activity and awareness in breast screening attendees in Black Country, UK, Health Promotion International, 10.1093/heapro/dau053, (dau053) Akther T, Nur T and Dragan D (2022) A model of factors influencing COVID-19 vaccine acceptance: A synthesis of the theory of reasoned action, conspiracy theory belief, awareness, perceived usefulness, and perceived ease of use, PLOS ONE, 10.1371/journal.pone.0261869, 17:1, (e0261869) May 1, 1996Vol 93, Issue 9 Advertisement Article InformationMetrics Copyright © 1996 by American Heart Associationhttps://doi.org/10.1161/01.CIR.93.9.1768 Originally publishedMay 1, 1996 Advertisement

Adult members who declined participation in cardiovascular disease risk factor screenings offered at religious organizations were randomly selected and asked to participate in screenings at their homes. Relationships between screening participation and sociodemographic, behavioral, and physiological measures were examined. Age, knowledge of cardiovascular disease risk factors, body mass index, current smoking status, previous report of elevated blood pressure, current diastolic blood pressure measurement, frequency of worship service attendance, and residential distance from the religious organization screening site were important predictors of screening response. Those with conspicuous risk factors appeared less likely to initially respond to religious organization site screening invitations.

Health promotion and intervention projects at State and community levels need computerized data bases to assist in making policy decisions and in operating the projects. Computer data base systems are used in entering, storing, retrieving, and analyzing information about health project activities and their participants in a timely and cost-effective manner. Computer support is essential for such labor-intensive tasks as post-screening followup of participants, identifying subpopulations, and evaluating recruitment efforts and behavior change programs. The Pawtucket Heart Health Program developed a microcomputer software package, FPbase, for community health project data base management. FPbase is described and is available for use by other organizations. FPbase incorporates formative and process interactive data base activities and is suitable for use in operating intervention and screening programs at State and local levels. The system accommodates management of data for social marketing, evaluation, followup, and promotional activities.

HomeCirculationVol. 83, No. 6Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction. A statement from the National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBReport of the Expert Panel on Population Strategies for Blood Cholesterol Reduction. A statement from the National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health. R A Carleton, J Dwyer, L Finberg, J Flora, D S Goodman, S M Grundy, S Havas, G T Hunter, D Kritchevsky and R M Lauer R A CarletonR A Carleton , J DwyerJ Dwyer , L FinbergL Finberg , J FloraJ Flora , D S GoodmanD S Goodman , S M GrundyS M Grundy , S HavasS Havas , G T HunterG T Hunter , D KritchevskyD Kritchevsky and R M LauerR M Lauer Originally published1 Jun 1991https://doi.org/10.1161/01.CIR.83.6.2154Circulation. 1991;83:2154–2232 Previous Back to top Next FiguresReferencesRelatedDetailsCited By Sáiz-Vazquez O, Puente-Martínez A, Ubillos-Landa S, Pacheco-Bonrostro J and Santabárbara J (2020) Cholesterol and Alzheimer's Disease Risk: A Meta-Meta-Analysis, Brain Sciences, 10.3390/brainsci10060386, 10:6, (386) Sempos C, Heijboer A, Bikle D, Bollerslev J, Bouillon R, Brannon P, DeLuca H, Jones G, Munns C, Bilezikian J, Giustina A and Binkley N (2018) Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D, British Journal of Clinical Pharmacology, 10.1111/bcp.13652, 84:10, (2194-2207), Online publication date: 1-Oct-2018. Perera R, McFadden E, McLellan J, Lung T, Clarke P, Pérez T, Fanshawe T, Dalton A, Farmer A, Glasziou P, Takahashi O, Stevens J, Irwig L, Hirst J, Stevens S, Leslie A, Ohde S, Deshpande G, Urayama K, Shine B and Stevens R (2015) Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling, Health Technology Assessment, 10.3310/hta191000, 19:100, (1-402) Zeltzer S, Taylor D and Tang W (2015) Long-term dietary habits and interventions in solid-organ transplantation, The Journal of Heart and Lung Transplantation, 10.1016/j.healun.2015.06.014, 34:11, (1357-1365), Online publication date: 1-Nov-2015. Ezzati M, Obermeyer Z, Tzoulaki I, Mayosi B, Elliott P and Leon D (2015) Contributions of risk factors and medical care to cardiovascular mortality trends, Nature Reviews Cardiology, 10.1038/nrcardio.2015.82, 12:9, (508-530), Online publication date: 1-Sep-2015. Zoellner J, Van Horn L, Gleason P and Boushey C (2015) What Is Translational Research? Concepts and Applications in Nutrition and Dietetics, Journal of the Academy of Nutrition and Dietetics, 10.1016/j.jand.2015.03.010, 115:7, (1057-1071), Online publication date: 1-Jul-2015. Su Y, Tian Y, Yan R, Wang C, Niu F and Yang Y (2014) Study on a novel process for the separation of phospholipids, triacylglycerol and cholesterol from egg yolk, Journal of Food Science and Technology, 10.1007/s13197-014-1513-5, 52:7, (4586-4592), Online publication date: 1-Jul-2015. R B and J B (2015) A STUDY OF DOSE DEPENDANT EFFECT OF CIGARETTE SMOKING ON LIPID PROFILE, Journal of Evolution of Medical and Dental Sciences, 10.14260/jemds/2015/169, 04:07, (1221-1229), Online publication date: 21-Jan-2015. Çaktü K, Baydemir G, Ergün B and Yavuz H (2013) Cholesterol removal from various samples by cholesterol-imprinted monosize microsphere-embedded cryogels, Artificial Cells, Nanomedicine, and Biotechnology, 10.3109/21691401.2013.832684, 42:6, (365-375), Online publication date: 1-Dec-2014. Arts J, Fernandez M and Lofgren I (2014) Coronary Heart Disease Risk Factors in College Students, Advances in Nutrition, 10.3945/an.113.005447, 5:2, (177-187), Online publication date: 1-Mar-2014. O'Gorman C, Syme C, Lang J, Bradley T, Wells G and Hamilton J (2013) An evaluation of early cardiometabolic risk factors in children and adolescents with Turner syndrome, Clinical Endocrinology, 10.1111/cen.12079, 78:6, (907-913), Online publication date: 1-Jun-2013. Pearson T, Palaniappan L, Artinian N, Carnethon M, Criqui M, Daniels S, Fonarow G, Fortmann S, Franklin B, Galloway J, Goff D, Heath G, Frank A, Kris-Etherton P, Labarthe D, Murabito J, Sacco R, Sasson C and Turner M (2013) American Heart Association Guide for Improving Cardiovascular Health at the Community Level, 2013 Update, Circulation, 127:16, (1730-1753), Online publication date: 23-Apr-2013. Maqdasy S, Baptissart M, Vega A, Baron S, Lobaccaro J and Volle D (2013) Cholesterol and male fertility: What about orphans and adopted?, Molecular and Cellular Endocrinology, 10.1016/j.mce.2012.06.011, 368:1-2, (30-46), Online publication date: 1-Apr-2013. Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M and Yokote K (2013) Diagnostic Criteria for Dyslipidemia, Journal of Atherosclerosis and Thrombosis, 10.5551/jat.17152, 20:8, (655-660), . de Zea Bermudez P and Mendes Z (2012) Extreme Value Theory in Medical Sciences: Modeling Total High Cholesterol Levels, Journal of Statistical Theory and Practice, 10.1080/15598608.2012.695673, 6:3, (468-491), Online publication date: 1-Sep-2012. Pearson T (2011) Public Policy Approaches to the Prevention of Heart Disease and Stroke, Circulation, 124:23, (2560-2571), Online publication date: 6-Dec-2011. Kang S, Kim Y, Muhlisin M, Song Y, Kim G and Lee S (2011) Effect of Dietary Palm Oil Supplementation on the Quality of Carcass and Meat of Hanwoo (Korean Cattle), Korean Journal for Food Science of Animal Resources, 10.5851/kosfa.2011.31.5.748, 31:5, (748-755), Online publication date: 31-Oct-2011. Anan K, Mitsuyama S, Yanagita Y, Kimura M, Doihara H, Komaki K, Kusama M and Ikeda T (2011) Effects of toremifene and anastrozole on serum lipids and bone metabolism in postmenopausal females with estrogen receptor–positive breast cancer: the results of a 2-year multicenter open randomized study, Breast Cancer Research and Treatment, 10.1007/s10549-011-1608-x, 128:3, (775-781), Online publication date: 1-Aug-2011. Hardoon S, Whincup P, Goya Wannamethee S, Lennon L, Capewell S and Morris R (2010) Assessing the impact of medication use on trends in major coronary risk factors in older British men: a cohort study, European Journal of Cardiovascular Prevention & Rehabilitation, 10.1097/HJR.0b013e3283378865, 17:5, (502-508), Online publication date: 1-Oct-2010. Simoneau-Roy J, O'Gorman C, Pencharz P, Adeli K, Daneman D and Hamilton J (2010) Insulin sensitivity and secretion in children and adolescents with hypothalamic obesity following treatment for craniopharyngioma, Clinical Endocrinology, 10.1111/j.1365-2265.2009.03639.x, 72:3, (364-370), Online publication date: 1-Mar-2010. SHIMADA K (2010) Should We Aggressively Treat the Patient with High Levels of Cholesterol Even in Japanese?, Health Evaluation and Promotion, 10.7143/jhep.37.673, 37:6, (673-678), . Hoogwerf B and Huang J (2010) Lipid-Lowering Strategies and Reduction of Coronary Heart Disease Risk Current Clinical Medicine, 10.1016/B978-1-4160-6643-9.00015-1, (81-86.e2), . Murphy G, Kaprielian V and Hoyo C (2009) Nutrition Handbook of Women's Health, 10.1017/CBO9780511642111.003, (25-42) (2009) Introduction Handbook of Women's Health, 10.1017/CBO9780511642111.001, (1-64) Santos A, Weiss T, Duarte C, Azevedo M and Zelmanovitz T (2009) Análise crítica das recomendações da Associação Americana de Diabetes para doença cardiovascular no diabetes melito, Arquivos Brasileiros de Endocrinologia & Metabologia, 10.1590/S0004-27302009000500018, 53:5, (657-666), Online publication date: 1-Jul-2009. Kang S, Cheong J, Pan J, Kang C and Lee S (2008) Quality Comparison of Beef from Outdoor-Reared before Finishing and Indoor-Reared Hanwoo, Korean Journal for Food Science of Animal Resources, 10.5851/kosfa.2008.28.5.629, 28:5, (629-636), Online publication date: 31-Dec-2009. Taylor C and Wilkening V (2008) How the Nutrition Food Label Was Developed, Part 1: The Nutrition Facts Panel, Journal of the American Dietetic Association, 10.1016/j.jada.2007.12.010, 108:3, (437-442), Online publication date: 1-Mar-2008. Nasiff-Hadad A and Magaly J (2008) Modification of a National Diet and Lifestyle Toward Wild-Type Foods Wild-Type Food in Health Promotion and Disease Prevention, 10.1007/978-1-59745-330-1_38, (545-554), . Gross M (2008) Lipids, Oxidation, and Cardiovascular Disease Atherosclerosis and Oxidant Stress, 10.1007/978-0-387-72347-1_5, (79-95), . O'Neil C and Nicklas T (2016) State of the Art Reviews: Relationship Between Diet/ Physical Activity and Health, American Journal of Lifestyle Medicine, 10.1177/1559827607306433., 1:6, (457-481), Online publication date: 1-Nov-2007. Woods C, Vanden Heuvel J and Rusyn I (2016) Genomic Profiling in Nuclear Receptor-Mediated Toxicity, Toxicologic Pathology, 10.1080/01926230701311351, 35:4, (474-494), Online publication date: 1-Jun-2007. HAN E, KIM S, AHN J and KWAK H (2007) Optimizing cholesterol removal from cream using ?-cyclodextrin cross-linked with adipic acid, International Journal of Dairy Technology, 10.1111/j.1471-0307.2007.00296.x, 60:1, (31-36), Online publication date: 1-Feb-2007. Teramoto T, Sasaki J, Ueshima H, Egusa G, Kinoshita M, Shimamoto K, Daida H, Biro S, Hirobe K, Funahashi T, Yokote K and Yokode M (2007) Executive Summary of Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases for Japanese, Journal of Atherosclerosis and Thrombosis, 10.5551/jat.14.45, 14:2, (45-50), . YANAI H and YOSHIDA H (2007) , Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 10.3999/jscpt.38.299, 38:5, (299-304), . Hellstrom H (2007) The altered homeostatic theory: A hypothesis proposed to be useful in understanding and preventing ischemic heart disease, hypertension, and diabetes – including reducing the risk of age and atherosclerosis, Medical Hypotheses, 10.1016/j.mehy.2006.05.031, 68:2, (415-433), Online publication date: 1-Jan-2007. Krasnoff J, Vintro A, Ascher N, Bass N, Paul S, Dodd M and Painter P (2006) A Randomized Trial of Exercise and Dietary Counseling After Liver Transplantation, American Journal of Transplantation, 10.1111/j.1600-6143.2006.01391.x, 6:8, (1896-1905), Online publication date: 1-Aug-2006. Kalaany N and Mangelsdorf D (2006) LXRS AND FXR: The Yin and Yang of Cholesterol and Fat Metabolism, Annual Review of Physiology, 10.1146/annurev.physiol.68.033104.152158, 68:1, (159-191), Online publication date: 1-Jan-2006. Croyle R, Loftus E, Barger S, Sun Y, Hart M and Gettig J (2006) How well do people recall risk factor test results? Accuracy and bias among cholesterol screening participants., Health Psychology, 10.1037/0278-6133.25.3.425, 25:3, (425-432) Miwa Y, Takiuchi S, Kamide K, Yoshii M, Horio T, Tanaka C, Banno M, Miyata T, Sasaguri T and Kawano Y (2005) Insertion/deletion polymorphism in clusterin gene influences serum lipid levels and carotid intima-media thickness in hypertensive Japanese females, Biochemical and Biophysical Research Communications, 10.1016/j.bbrc.2005.04.069, 331:4, (1587-1593), Online publication date: 1-Jun-2005. Sempos C, Gillum R and Looker A (2005) Iron and Heart Disease Preventive Nutrition, 10.1007/978-1-59259-880-9_7, (173-190), . Pearson T (2004) The epidemiologic basis for population-wide cholesterol reduction in the primary prevention of coronary artery disease, The American Journal of Cardiology, 10.1016/j.amjcard.2004.07.046, 94:9, (4-8), Online publication date: 1-Nov-2004. Kwak H, Kim S, Kim J, Choi H and Kang J (2004) Immobilized β-cyclodextrin as a simple and recyclable method for cholesterol removal in milk, Archives of Pharmacal Research, 10.1007/BF02980182, 27:8, (873-877), Online publication date: 1-Aug-2004. Varela A, Oliete B, Moreno T, Portela C, Monserrrat L, Carballo J and Sánchez L (2004) Effect of pasture finishing on the meat characteristics and intramuscular fatty acid profile of steers of the Rubia Gallega breed, Meat Science, 10.1016/j.meatsci.2003.12.005, 67:3, (515-522), Online publication date: 1-Jul-2004. Bemelmans W (2003) Effects of Nutritional Education on Cardiovascular Risk Factors Nutrition and Heart Disease, 10.1201/9780203507629.ch5, Online publication date: 17-Dec-2003. (2003) Effects of Nutritional Education on Cardiovascular Risk Factors Nutrition and Heart Disease, 10.1201/9780203507629-10, (81-88) Carlson J and Monti V (2003) The Role of Inclusive Dietary Patterns for Achieving Secondary Prevention Cardiovascular Nutrition Guidelines and Optimal Cardiovascular Health, Journal of Cardiopulmonary Rehabilitation, 10.1097/00008483-200309000-00001, 23:5, (322-333), Online publication date: 1-Sep-2003. Lucas G, Chaisson R and Moore R (2003) Survival in an Urban HIV-1 Clinic in the Era of Highly Active Antiretroviral Therapy: A 5-Year Cohort Study, JAIDS Journal of Acquired Immune Deficiency Syndromes, 10.1097/00126334-200307010-00005, 33:3, (321-328), Online publication date: 1-Jul-2003. Gill J, Brown J, Caslake M, Wright D, Cooney J, Bedford D, Hughes D, Stanley J and Packard C (2003) Effects of dietary monounsaturated fatty acids on lipoprotein concentrations, compositions, and subfraction distributions and on VLDL apolipoprotein B kinetics: dose-dependent effects on LDL, The American Journal of Clinical Nutrition, 10.1093/ajcn/78.1.47, 78:1, (47-56), Online publication date: 1-Jul-2003. Gilmer T and O???Connor P (2003) Cost Effectiveness of Diabetes Mellitus Management Programs, Disease Management & Health Outcomes, 10.2165/00115677-200311070-00004, 11:7, (439-453), . Jackson R, Al-Mousa Z, Al-Raqua M, Prakash P and Muhanna A (2002) Multiple coronary risk factors in healthy older Kuwaiti males, European Journal of Clinical Nutrition, 10.1038/sj.ejcn.1601379, 56:8, (709-714), Online publication date: 1-Aug-2002. Bemelmans W, Lefrandt J, Feskens E, Broer J, Tervaert J, May J and Smit A (2002) Change in saturated fat intake is associated with progression of carotid and femoral intima-media thickness, and with levels of soluble intercellular adhesion molecule-1, Atherosclerosis, 10.1016/S0021-9150(01)00747-X, 163:1, (113-120), Online publication date: 1-Jul-2002. Wanke C, Falutz J, Shevitz A, Phair J and Kotler D (2002) Clinical Evaluation and Management of Metabolic and Morphologic Abnormalities Associated with Human Immunodeficiency Virus, Clinical Infectious Diseases, 10.1086/324744, 34:2, (248-259), Online publication date: 15-Jan-2002. Mistry D and Medrano J (2002) Cloning and Localization of the Bovine and Ovine Lysophosphatidic Acid Acyltransferase (LPAAT) Genes that Codes for an Enzyme Involved in Triglyceride Biosynthesis, Journal of Dairy Science, 10.3168/jds.S0022-0302(02)74049-6, 85:1, (28-35), Online publication date: 1-Jan-2002. Deniel Rosanas J, Prat Quinzaños J, Gallego Quiroga C, Rosique Samper P and Farré Guerrero V (2002) Niveles de colesterol sérico en una población de Cataluña. Evolución en un período de 6 años (1994–1999), Atención Primaria, 10.1016/S0212-6567(02)70565-9, 29:5, (278-286), . Velasco S, Cañeque V, Pérez C, Lauzurica S, Dı́az M, Huidobro F, Manzanares C and González J (2001) Fatty acid composition of adipose depots of suckling lambs raised under different production systems, Meat Science, 10.1016/S0309-1740(01)00135-8, 59:3, (325-333), Online publication date: 1-Nov-2001. Pearson T (2001) Nutritional interventions to reduce cardiovascular disease: Individual versus population perspectives, Current Atherosclerosis Reports, 10.1007/s11883-001-0030-y, 3:6, (425-427), Online publication date: 1-Nov-2001. Mohan V, Deepa R, Shanthi Rani S and Premalatha G (2001) Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India, Journal of the American College of Cardiology, 10.1016/S0735-1097(01)01415-2, 38:3, (682-687), Online publication date: 1-Sep-2001. Pearson T, Wall S, Lewis C, Jenkins P, Nafziger A and Weinehall L (2017) Dissecting the ``black box' ' of community intervention: Lessons from community-wide cardiovascular disease prevention programs in the US and Sweden, Scandinavian Journal of Public Health, 10.1177/14034948010290022001, 29:56_suppl, (69-78), Online publication date: 1-Jun-2001. Weinehall L, Hellsten G, Boman K, Hallmans G, Asplund K and Wall S (2017) Can a sustainable community intervention reduce the health gap? -10-Year evaluation of a Swedish community intervention program for the prevention of cardiovascular disease, Scandinavian Journal of Public Health, 10.1177/14034948010290021901, 29:56_suppl, (59-68), Online publication date: 1-Jun-2001. Veazie P (2001) Using Computer Simulation to Investigate Disease Management, The Endocrinologist, 10.1097/00019616-200105000-00008, 11:3, (209-216), Online publication date: 1-May-2001. (2001) A comparison of knowledge and attitudes about diet and health among 35- to 75-year-old adults in the United States and Geneva, Switzerland, American Journal of Public Health, 10.2105/AJPH.91.3.418, 91:3, (418-424), Online publication date: 1-Mar-2001. German J and Walzem R (2000) T HE H EALTH B ENEFITS OF W INE , Annual Review of Nutrition, 10.1146/annurev.nutr.20.1.561, 20:1, (561-593), Online publication date: 1-Jul-2000. Borghi C, Prandin M, Costa F, Bacchelli S, Esposti D and Ambrosioni E (2000) Use of Statins and Blood Pressure Control in Treated Hypertensive Patients with Hypercholesterolemia, Journal of Cardiovascular Pharmacology, 10.1097/00005344-200004000-00006, 35:4, (549-555), Online publication date: 1-Apr-2000. HORN L (2000) Primary Prevention of Cardiovascular Disease Starts in Childhood, Journal of the American Dietetic Association, 10.1016/S0002-8223(00)00017-1, 100:1, (41-42), Online publication date: 1-Jan-2000. OLSON R (2000) Is It Wise to Restrict Fat in the Diets of Children?, Journal of the American Dietetic Association, 10.1016/S0002-8223(00)00012-2, 100:1, (28-32), Online publication date: 1-Jan-2000. Sacks F (2000) Role Of Lipid Concentrations and Apolipoproteins In Altering ApoB Metabolism and Promoting Coronary Events Lipoprotein Metabolism and Atherogenesis, 10.1007/978-4-431-68424-4_2, (12-18), . Böhm M, Diet F, Flesch M, Laufs U, Nickenig G and Schnabel P (2000) Weitere kardiovaskuläre Risikofaktoren Klinische Kardiologie, 10.1007/978-3-662-12156-6_16, (269-291), . Böhm M, Diet F, Flesch M, Laufs U, Nickenig G and Schnabel P (2000) Arterielle Hypertonie Klinische Kardiologie, 10.1007/978-3-662-12156-6_15, (259-268), . Böhm M, Diet F, Flesch M, Laufs U, Nickenig G and Schnabel P (2000) Fettstoffwechsel, Übergewicht und Ernährung, Diabetes Klinische Kardiologie, 10.1007/978-3-662-12156-6_14, (239-257), . Williams C, Bollella M, Strobino B, Boccia L and Campanaro L (1999) Plant Stanol Ester and Bran Fiber in Childhood: Effects on Lipids, Stool Weight and Stool Frequency in Preschool Children, Journal of the American College of Nutrition, 10.1080/07315724.1999.10718891, 18:6, (572-581), Online publication date: 1-Dec-1999. Lee D, Ahn J and Kwak H (1999) Cholesterol Removal from Homogenized Milk with β-Cyclodextrin, Journal of Dairy Science, 10.3168/jds.S0022-0302(99)75481-0, 82:11, (2327-2330), Online publication date: 1-Nov-1999. Goldman L, Coxson P, Hunink M, Goldman P, Tosteson A, Mittleman M, Williams L and Weinstein M (1999) The relative influence of secondary versus primary prevention using the National Cholesterol Education Program Adult Treatment Panel II guidelines, Journal of the American College of Cardiology, 10.1016/S0735-1097(99)00260-0, 34:3, (768-776), Online publication date: 1-Sep-1999. Grundy S (1999) THE OPTIMAL RATIO OF FAT-TO-CARBOHYDRATE IN THE DIET, Annual Review of Nutrition, 10.1146/annurev.nutr.19.1.325, 19:1, (325-341), Online publication date: 1-Jul-1999. Spósito A, Mansur A, Coelho O, Nicolau J and Ramires J (1999) Additional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril), The American Journal of Cardiology, 10.1016/S0002-9149(99)00132-0, 83:10, (1497-1499), Online publication date: 1-May-1999. Weinehall L, Westman G, Hellsten G, Boman K, Hallmans G, Pearson T and Wall S (1999) Shifting the distribution of risk: results of a community intervention in a Swedish programme for the prevention of cardiovascular disease, Journal of Epidemiology & Community Health, 10.1136/jech.53.4.243, 53:4, (243-250), Online publication date: 1-Apr-1999. Phillips K, Tarragó-Trani M and Stewart K (1999) Phytosterol content of experimental diets differing in fatty acid composition, Food Chemistry, 10.1016/S0308-8146(98)00090-9, 64:3, (415-422), Online publication date: 1-Feb-1999. Spósito A, Caramelli B, Serrano C, Mansur A and Ramires J (1999) Effect of niacin and etofibrate association on subjects with coronary artery disease and serum high-density lipoprotein cholesterol <35 mg/dl, The American Journal of Cardiology, 10.1016/S0002-9149(98)00787-5, 83:1, (98-100), Online publication date: 1-Jan-1999. Miller M (1999) Triglyceride as a risk factor, epidemiology, Lipids, 10.1007/BF02562314, 34:S1, (S267-S267), Online publication date: 1-Jan-1999. Citkowitz E and Herbert P (1999) Lipoproteins and Apoproteins Contemporary Concepts in Cardiology, 10.1007/978-1-4615-5007-5_3, (28-68), . Sacks F (1998) Why cholesterol as a central theme in coronary artery disease?, The American Journal of Cardiology, 10.1016/S0002-9149(98)00717-6, 82:10, (14-17), Online publication date: 1-Nov-1998. Miyake T and Shibamoto T (1998) Formation of Malonaldehyde in the Presence of Probucol, an Anti-atherosclerosis Drug, Food and Chemical Toxicology, 10.1016/S0278-6915(98)00062-3, 36:9-10, (841-847), Online publication date: 1-Sep-1998. Gray R, Malla S and Stephen A (1998) Canadian Dietary Fat Substitutions, 1955-93, and Coronary Heart Disease Costs, Canadian Journal of Agricultural Economics/Revue canadienne d'agroeconomie, 10.1111/j.1744-7976.1998.tb00365.x, 46:2, (233-246), Online publication date: 1-Jul-1998. Tybjærg-Hansen A, Steffensen R, Meinertz H, Schnohr P and Nordestgaard B (1998) Association of Mutations in the Apolipoprotein B Gene with Hypercholesterolemia and the Risk of Ischemic Heart Disease, New England Journal of Medicine, 10.1056/NEJM199805283382203, 338:22, (1577-1584), Online publication date: 28-May-1998. Mengelkoch L, Pollock M, Limacher M, Graves J, Shireman R, Riley W, Lowenthal D and Leon A (2015) Effects of Age, Physical Training, and Physical Fitness on Coronary Heart Disease Risk Factors in Older Track Athletes at Twenty-Year Follow-up, Journal of the American Geriatrics Society, 10.1111/j.1532-5415.1997.tb03194.x, 45:12, (1446-1453), Online publication date: 1-Dec-1997. Murdoch M and Wilt T (1997) Cholesterol Awareness After Case-Finding: Do Patients Really Know Their Cholesterol Numbers?, American Journal of Preventive Medicine, 10.1016/S0749-3797(18)30176-4, 13:4, (284-289), Online publication date: 1-Jul-1997. Bottoni A, Cannella C and Del Balzo V (1997) Lifestyle and dietary differences in smokers and non-smokers from an Italian employee population, Public Health, 10.1016/S0033-3506(97)00576-3, 111:3, (161-164), Online publication date: 1-May-1997. Cleeman J (1997) Adults aged 20 and older should have their cholesterol measured, The American Journal of Medicine, 10.1016/S0002-9343(97)00465-8, 102:2, (31-36), Online publication date: 1-Feb-1997. Sempos C, Looker A and Gillum R (2009) Iron and Heart Disease: The Epidemiologic Data, Nutrition Reviews, 10.1111/j.1753-4887.1996.tb03875.x, 54:3, (73-84) Namekata T, Moore D, Knopp R, Marcovina S, Perrin E, Hughes D, Suzuki K, Mori M, Sempos C, Hatano S, Hayashi C and Hasegawa M (1996) Cholesterol Levels among Japanese Americans and Other Populations : Seattle Nikkei Health Study, Journal of Atherosclerosis and Thrombosis, 10.5551/jat1994.3.105, 3:2, (105-113), . Hachey D, Pond W and Wong W (1996) Is dietary cholesterol beneficial to the infant? Recent Developments in Infant Nutrition, 10.1007/978-94-009-1790-3_18, (251-259), . Kaplan J, Fontenot M, Manuck S and Muldoon M (1999) Influence of dietary lipids on agonistic and affiliative behavior in Macaca fascicularis , American Journal of Primatology, 10.1002/(SICI)1098-2345(1996)38:4<333::AID-AJP4>3.0.CO;2-#, 38:4, (333-347), Online publication date: 1-Jan-1996. Nielsen L, Leth-Espensen P, Nordestgaard B, Forged E, Kjeldsen K and Stender S (2007) Replacement of dietary saturated fat with monounsaturated fat: effect on atherogenesis in cholesterol-fed rabbits clamped at the same plasma cholesterol level, British Journal of Nutrition, 10.1079/BJN19950154, 74:4, (509-521), Online publication date: 1-Oct-1995. Loria C, Bush T, Carroll M, Looker A, McDowell M, Johnson C and Sempos C (1995) Macronutrient intakes among adult Hispanics: a comparison of Mexican Americans, Cuban Americans, and mainland Puerto Ricans., American Journal of Public Health, 10.2105/AJPH.85.5.684, 85:5, (684-689), Online publication date: 1-May-1995. Deedwania P (1995) Clinical perspectives on primary and secondary prevention of coronary atherosclerosis, Medical Clinics of North America, 10.1016/S0025-7125(16)30017-7, 79:5, (973-998), . Kumanyika S, Tell G, Shemanski L, Polak J and Savage P (1994) Eating patterns of community-dwelling older adults: The cardiovascular health study, Annals of Epidemiology, 10.1016/1047-2797(94)90076-0, 4:5, (404-415), Online publication date: 1-Sep-1994. Dallongeville J, Leboeuf N, Blais C, Touchette J, Gervais N and Davignon J (1994) Short-term response to dietary counseling of hyperlipidemic outpatients of a lipid clinic, Journal of the American Dietetic Association, 10.1016/0002-8223(94)90156-2, 94:6, (616-621), Online publication date: 1-Jun-1994. Chait A, Brunzell J, Denke M, Eisenberg D, Ernst N, Franklin F, Ginsberg H, Kotchen T, Kuller L and Mullis R (1993) Rationale of the diet-heart statement of the American Heart Association. Report of the Nutrition Committee., Circulation, 88:6, (3008-3029), Online publication date: 1-Dec-1993. Bennett S (2010) Inequalities in risk factors and cardiovascular mortality among Australia's immigrants, Australian Journal of Public Health, 10.1111/j.1753-6405.1993.tb00145.x, 17:3, (251-261) James J, Auld G and Slater M (1993) Dietitians' knowledge structure relative to fat and cholesterol, Journal of Nutrition Education, 10.1016/S0022-3182(12)81114-9, 25:4, (193-200), Online publication date: 1-Jul-1993. Sabate J, Fraser G, Burke K, Knutsen S, Bennett H and Lindsted K (1993) Effects of Walnuts on Serum Lipid Levels and Blood Pressure in Normal Men, New England Journal of Medicine, 10.1056/NEJM199303043280902, 328:9, (603-607), Online publication date: 4-Mar-1993. Berner L (1993) Defining the Role of Milkfat in Balanced Diets , 10.1016/S1043-4526(08)60117-5, (131-257), . Betteridge D and Barth J (1992) Summary, International Journal of Cardiology, 10.1016/0167-5273(92)90346-5, 37, (S3-S11), Online publication date: 1-Oct-1992. Kingsley C and Gupta S (2016) How to reduce the risk of coronary artery disease, Postgraduate Medicine, 10.1080/00325481.1992.11701250, 91:4, (147-160), Online publication date: 1-Mar-1992. (1991) Should trials carry a health warning?, The Lancet, 10.1016/0140-6736(91)92307-N, 338:8781, (1495-1496), Online publication date: 1-Dec-1991. June 1, 1991Vol 83, Issue 6 Advertisement Article InformationMetrics Copyright © 1991 by American Heart Associationhttps://doi.org/10.1161/01.CIR.83.6.2154 Originally publishedJune 1, 1991 PDF download Advertisement

This project studies the use of church volunteers to reduce cardiovascular disease risk factors among their fellow church members. Our findings focus on the first 12 months of the project and address the following questions: 1) Can volunteers implement these programs with no on-site professional staff? 2) Are volunteer efforts facilitated by a local volunteer task force? and 3) Are implementation efforts aided by readily available professional staff involvement? In the intervention churches, 220 certified Risk Factor Leaders conducted 82 group programs with 740 registrants and 104 blood pressure screenings with 1,834 contacts. Our study shows volunteers to be effective implementers of heart health programs in churches. The involvement of a task force seemed to facilitate volunteer recruitment. Churches with a lower level of professional involvement had more blood pressure screenings. The effect of a task force or professional assistance on other volunteer efforts did not reach statistical significance.

The Brown University Program-in-Medicine, Providence, R.I. 02906 and the Division of Nutrition and Metabolism, The Miriam Hospital, Providence, R.I. 02906

An easily applicable lead system similar to that proposed by Mason and Likar in 1966 for stress electrocardiography provides quantitative and qualitative electrocardiographic information and diagnoses similar to those derived from the “standard” lead system using only torso placement of ten electrodes.

The mechanisms and potential mediator of hypercapneic pulmonary hypertension are incompletely understood. We studied 18 dogs, anaesthetised and spontaneously breathing both room air and after the inhalation of a gas mixture containing 10% CO2, 20.9% O2, and 69.1% N2, to determine the role of histamine, serotonin, and acidaemia in pulmonary hypertension produced by hypercapnia. Hypercapnia increased the mean pulmonary artery pressure by 0.33 kPa (2.5 mmHg) while wedge pressure and pulmonary arteriolar resistance did not change. Cardiac output significantly increased, indicating that the pulmonary hypertensive effect of hypercapnia is mainly flow related. Neither chlorpheniramine nor methysergide had significant effects on hypercapneic pulmonary hypertension. The infusion of sodium bicarbonate corrected the pH; pulmonary artery pressure and cardiac output increased while pulmonary arteriolar resistance dropped, suggesting that the increased cardiac output masked the effect of pH on pulmonary arteriolar resistance. The lack of effect of chlorpheniramine or methysergide on pulmonary resistances indicates that the vasoconstrictive effect of increased hydrogen ion concentration which accompanies hypercapnia is attributable neither to histamine nor to serotonin release.

During exposure to 8 percent oxygen inhalation, 18 dogs experienced an average increase of 5.4 mm Hg in mean pulmonary arterial pressure. The administration of promethazine and chlorpheniramine during an initial exposure to hypoxia significantly decreased the pulmonary hypoxic pressor response; the administration of diphenhydramine did not. However, these 3 antihistaminic agents prevented the development of pulmonary hypertension during a second exposure to hypoxia (P = 0.3 × 10−6). Five dogs received progressive doses of chlorpheniramine, thus showing that the effectiveness of this drug can be demonstrated at a dose of less than 0.3 mg/kg body weight. The amounts of diphenhydramine and promethazine needed to achieve effectiveness equivalent to that of chlorpheniramine are sufficiently great as to restrict their applicability to man in acceptable doses. This study lends further support to the hypothesis that histamine mediates hypoxic pulmonary hypertension.

The occurrence of cardiovascular lesions in individuals with rheumatoid arthritis has been recognized for many years.1Manifestations attributed to the rheumatoid process include valvular, myocardial, and pericardial lesions,2-6as well as systemic arteritis.7,8Arteritis of the coronary vessels has been found at autopsy in as many as 20% of the cases,9but only rarely has this complication been diagnosed during life. The clinical diagnosis of acute myocardial infarction due to rheumatoid coronary arteritis was not reported until as recently as 1967,10,11although the pathological association had been previously recognized.5,7,12 We describe the clinical and coronary cineangiographic features of a patient with rheumatoid coronary arteritis in whom angina pectoris was treated by a saphenous vein aortocoronary bypass. Patient Summary A 35-year-old white woman was admitted to Rush-Presbyterian-St. Luke's Medical Center on May 9,1971. For several years, the patient had been experiencing oppressive precordial pain and

Inhalation of 8 per cent oxygen produced pulmonary hypertension in only 13 of 22 dogs anesthetized with pentobarbital. Conversely, each of the dogs anesthetized with a mixture of droperidol and fentanyl developed hypoxic pulmonary hypertension (p = 0.0055), with an increased in the average mean pulmonary artery pressure from 9.7 ± 0.55 (S.E.) to 13.2 ± 0.77 mm. Hg. The average calculated pulmonary arteriolar resistance increased from 280 to 353 dynes-sec.-cm.−5 without significant change in the pulmonary arterial wedge pressure. This analgesic-neuroleptic combination provides satisfactory anesthesia for studies of hypoxic pulmonary hypertension in dogs.

ArticlePrevention of hypoxic pulmonary hypertension by chlorpheniramine.A Susmano, and R A CarletonA Susmano, and R A CarletonPublished Online:01 Oct 1971https://doi.org/10.1152/jappl.1971.31.4.531MoreSectionsPDF (1 MB)Download PDF ToolsExport citationAdd to favoritesGet permissionsTrack citations ShareShare onFacebookTwitterLinkedInWeChat Previous Back to Top Next Download PDF FiguresReferencesRelatedInformation Cited ByHypoxic Pulmonary VasoconstrictionJ. T. Sylvester, Larissa A. Shimoda, Philip I. Aaronson, and Jeremy P. T. Ward1 January 2012 | Physiological Reviews, Vol. 92, No. 1Endothelium-derived nitric oxide regulates systemic and pulmonary vascular resistance during acute hypoxia in humansJournal of the American College of Cardiology, Vol. 28, No. 3Effects of H1 and H2 histamine antagonists on the pulmonary pressor response to alveolar hypoxiaJournal of Surgical Research, Vol. 22, No. 4Hypoxia on the pulmonary circulation. How and where it acts.Circulation Research, Vol. 38, No. 4Factors causing and reversing vasoconstriction in unventilated lungRespiration Physiology, Vol. 24, No. 3Role of histamine in the hypoxic vascular response of the lungRespiration Physiology, Vol. 24, No. 1Effect of antihistaminic drugs on hypoxic pulmonary hypertensionThe American Journal of Cardiology, Vol. 31, No. 6Noncardiogenic Forms of Pulmonary EdemaCirculation, Vol. 46, No. 2 More from this issue > Volume 31Issue 4October 1971Pages 531-5 https://doi.org/10.1152/jappl.1971.31.4.531PubMed5110997History Published online 1 October 1971 Published in print 1 October 1971 Metrics